CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02091245
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:54.069930+00:00
Published At: 2025-12-02T00:00:00+00:00
Record Updated At: 2025-12-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Relapsed Acute Lymphoblastic Leukemia (ALL)", "Refractory Acute Lymphoblastic Leukemia (ALL)", "Relapsed Acute Myelogenous Leukemia (AML)", "Refractory Acute Myelogenous Leukemia (AML)", "Relapsed Mixed Lineage Leukemia", "Refractory Mixed Lineage Leukemia", "Relapsed Biphenotypic Leukemia", "Refractory Biphenotypic Leukemia", "Chronic Myelogenous Leukemia (CML) in Blast Crisis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-02"
protocolSection.identificationModule.nctId: "NCT02091245"
protocolSection.identificationModule.officialTitle: "Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML."
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.